First-line therapy with gemcitabine and paclitaxel in locally, recurrent or metastatic breast cancer: A phase II study

被引：0
|
作者：
Djelila Allouache
Sulochana R Gawande
Michele Tubiana-Hulin
Nicole Tubiana-Mathieu
Sophie Piperno-Neumann
Fawzia Mefti
Laurence Bozec
Jean-Yves Genot
机构：
[1] Lion sur mer,Centre F. Baclesse
[2] Lilly Corporate,Eli Lilly and Company
[3] Ctr René Huguenin,undefined
[4] Hopital Dupuytren,undefined
[5] Hospital Curie,undefined
[6] Lilly France,undefined
来源：
BMC Cancer | / 5卷
关键词：
Paclitaxel; Gemcitabine; Metastatic Breast Cancer; Anthracyclines; Inflammatory Breast Cancer;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] The Breast Avastin Trial: phase II study of bevacizumab maintenance therapy after induction chemotherapy with docetaxel and capecitabine for the first-line treatment of patients with locally recurrent or metastatic breast cancer
    Bisagni, G.
    Musolino, A.
    Panebianco, M.
    De Matteis, A.
    Nuzzo, F.
    Ardizzoni, A.
    Gori, S.
    Gamucci, T.
    Passalacqua, R.
    Gnoni, R.
    Moretti, G.
    Boni, C.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2013, 71 (04) : 1051 - 1057
  • [22] A phase II trial of a biweekly combination of paclitaxel and gemcitabine in metastatic breast cancer
    Silverio Tomao
    Adriana Romiti
    Federica Tomao
    Marisa Di Seri
    Giuliana Caprio
    Gian Paolo Spinelli
    Edmondo Terzoli
    Luigi Frati
    BMC Cancer, 6
  • [23] Phase II study of gefitinib in combination with docetaxel as first-line therapy in metastatic breast cancer
    Ciardiello, F.
    Troiani, T.
    Caputo, F.
    De Laurentiis, M.
    Tortora, G.
    Palmieri, G.
    De Vita, F.
    Diadema, M. R.
    Orditura, M.
    Colantuoni, G.
    Gridelli, C.
    Catalano, G.
    De Placido, S.
    Bianco, A. R.
    BRITISH JOURNAL OF CANCER, 2006, 94 (11) : 1604 - 1609
  • [24] Phase II study of gefitinib in combination with docetaxel as first-line therapy in metastatic breast cancer
    F Ciardiello
    T Troiani
    F Caputo
    M De Laurentiis
    G Tortora
    G Palmieri
    F De Vita
    M R Diadema
    M Orditura
    G Colantuoni
    C Gridelli
    G Catalano
    S De Placido
    A R Bianco
    British Journal of Cancer, 2006, 94 : 1604 - 1609
  • [25] Final results of a phase II study of nab-paclitaxel, bevacizumab, and gemcitabine as first-line therapy for patients with HER2-negative metastatic breast cancer
    Christopher Lobo
    Gilberto Lopes
    Odalys Baez
    Aurelio Castrellon
    Annapoorna Ferrell
    Connie Higgins
    Erin Hurley
    Judith Hurley
    Isildinha Reis
    Stephen Richman
    Pearl Seo
    Orlando Silva
    Joyce Slingerland
    Keleni Tukia
    Catherine Welsh
    Stefan Glück
    Breast Cancer Research and Treatment, 2010, 123 : 427 - 435
  • [26] Capecitabine and weekly paclitaxel as first-line therapy in Thai patients with metastatic breast cancer
    Chitapanarux, Imjai
    Kamnerdsupaphon, Pimkhuan
    Tharavichitkul, Ekasit
    Lorvidhaya, Vicharn
    Trakultivakorn, Hongsin
    Srisukho, Songpol
    Somwangprasert, Areewan
    Watcharachan, Kirati
    Sukthomya, Vimol
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2012, 8 (01) : 76 - 82
  • [27] Phase II study of carboplatin followed by sequential gemcitabine and paclitaxel as first-line treatment for advanced ovarian cancer
    Friedlander, M.
    Buck, M.
    Wyld, D.
    Findlay, M.
    Fitzharris, B.
    De Souza, P.
    Davies, T.
    Kalimi, G.
    Allan, S.
    Perez, D.
    Harnett, P.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2007, 17 (02) : 350 - 358
  • [28] Paclitaxel, Epirubicin and Capecitabine (TEX) as First-Line Treatment for Metastatic Breast Cancer: a Pilot Phase I/II Feasibility Study
    Einbeigi, Z.
    Bergstrom, D.
    Hatschek, T.
    Malmberg, M.
    CLINICAL MEDICINE INSIGHTS-ONCOLOGY, 2008, 2 : 533 - 538
  • [29] Final results of a phase II study of nab-paclitaxel, bevacizumab, and gemcitabine as first-line therapy for patients with HER2-negative metastatic breast cancer
    Lobo, Christopher
    Lopes, Gilberto
    Baez, Odalys
    Castrellon, Aurelio
    Ferrell, Annapoorna
    Higgins, Connie
    Hurley, Erin
    Hurley, Judith
    Reis, Isildinha
    Richman, Stephen
    Seo, Pearl
    Silva, Orlando
    Slingerland, Joyce
    Tukia, Keleni
    Welsh, Catherine
    Glueck, Stefan
    BREAST CANCER RESEARCH AND TREATMENT, 2010, 123 (02) : 427 - 435
  • [30] A randomized, phase II, three-arm study of two schedules of ixabepilone or paclitaxel plus bevacizumab as first-line therapy for metastatic breast cancer
    Rugo, Hope S.
    Campone, Mario
    Amadori, Dino
    Aldrighetti, Daniela
    Conte, PierFranco
    Wardley, Andrew
    Villanueva, Cristian
    Melisko, Michelle
    McHenry, M. Brent
    Liu, David
    Lee, Francis
    Pivot, Xavier
    BREAST CANCER RESEARCH AND TREATMENT, 2013, 139 (02) : 411 - 419
12345